Topical capecitabine for the treatment of hyperproliferative skin conditions
EP3506906A1
Fenoldopam topical formulations for treating skin disorders
US10548837B1
Topical montelukast for treatment of atopic dermatitis
IL229669D0
Process for preparation of 1,2,3 -triazole-4-carboxamides
WO2012123945A1
Process for the preparation of a stable polymorphic form of atovaquone
WO2012032508A1
Process for the preparation of 2-phenyl-1,3-propanediol
EP2596007A1
Process for the preparation of 17-desoxy-corticosteroids
WO2010038234A1
Combination product of spironolactone and doxycycline
AU2007200460A1
Non-sedating barbiturate compounds as neuroprotective agents
IL180493D0
Process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid
IL179086D0
Process for preparing ondansetron hydrochloride dihydrate having a defined particle size
AU2006208416A1
Taste masking spill-resistant formulation
US2006063725A1
Process of preparing a crystalline azithromycin monohydrate
US2006041004A1
Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one and ondansetron therefrom
WO2006024138A1
A thermoreversible pharmaceutical formulation for anti-microbial agents comprising poloxamer polymers and hydroxy fatty acid ester of polyethylene glycol
WO2006017263A1
Topical gel formulation comprising organophosphate insecticide and its preparation thereof
EP1781624A2
A process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid
US2005261351A1
Process for preparing ondansetron hydrochloride dihydrate having a defined particle size
AU2004229086A1
Non-sedating barbiturate compounds as neuroprotective agents
